Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2015) 39 EP114 | DOI: 10.1530/endoabs.39.EP114

BSPED2015 e-Posters Pituitary and growth (18 abstracts)

Growth monitoring in girls attending a tertiary paediatric ENT service with middle ear disease

Morven Bremner 1 , Amy Carbarns 1 , Ismail Essa 1 , Rebecca Bradley 1 , Sze Choong Wong 2 , Avril Mason 2 & Haytham Kubba 2


1University of Glasgow, Glasgow, UK; 2RHSC Glasgow, Glasgow, UK.


Background: Recurrent middle ear disease may lead to poor growth or may suggest an underlying diagnosis associated with short stature. The aim of the study was to describe stature in a cohort of girls attending a paediatric ENT service.

Methods: Height and weight was measured in all girls attending ENT clinics over an 8 week period (n=83). A mid-parental height (MPH) was calculated from reported parental heights. The final ENT diagnosis was catergorised as: otitis media with effusion (group 1); recurrent acute otitis media (group 2); cholesteatoma (group 3); or otitis media with perforation (group 4).

Results: For the whole group the median age was 5.89 years (0.82, 14.49), median height SDS was 0.09 (−4.13, 2.86), median BMISDS was 0.44 (−2.49, 4.12). 2/83 girls (2.4%) had both height <−2S.D. and >1.5S.D. lower than MPHSDS, (Trisomy 21, short stature under paediatric review). An additional 7/83 (8.4%) had height >1.5S.D. lower than MPHSDS. The median age, either height parameter effected, (n=9) was 5.67 (2.38, 14.49); median height SDS −0.76(−4.13, −0.28) and median BMISDS −0.33(−1.53, 2.37).

Group 1Group 2Group 3Group 4
Number522371
Median age (range)6.02 (0.82, 14.49)4.13 (1.45, 9.80)9.28 (4.65, 11.64)3.72
Median height SDS (range)0.15 (−4.13, 2.86)−0.34 (−1.26, 1.39)0.27 (−1.35, 0.67)0.43
BMISDS (range)0.51 (−1.53, 4.19)0.23 (−2.85, 2.71)0.45 (−1.01, 2.22)2.18
Median height SDS-MPHSDS (range)−0.04 (−3.91, 2.92)−0.62 (−2.11, 2.62)−0.17 (−1.30, 2.38)−0.10

Conclusion: Most girls attending an ENT tertiary service with middle ear disease had a height within the normal range. However, 10.8% may be shorter than their genetic potential.

Volume 39

43rd Meeting of the British Society for Paediatric Endocrinology and Diabetes

British Society for Paediatric Endocrinology and Diabetes 

Browse other volumes

Article tools

My recent searches

No recent searches.